About T1D Exchange
T1D Exchange is a nonprofit organization focused on improving the lives of people living with diabetes.
OUR MISSION
Driving real-world evidence and collaborative change
OUR VISION
Better, longer lives for all people with T1D
Board of Directors

Rick Altinger
Consultant/Advisor
Medical Devices & Digital Therapeutics

John L Brooks III
Healthcare Capital
Managing Director

Phillip Cagnassola
Frasier Capital LLC
President

Jack Collins
P&B Intermodal Services
Senior Vice President of Finance

Kevin Larsen
MD
OptumLabs
Senior Vice President Clinical Innovation & Translation

Jay Mohr
Dirigo Therapeutics, LLC
Founder/President & CEO

Juan Frias
MD
Los Angeles Institute for Metabolic Research
Medical Director & Principal Investigator

Brian Novak
Ph.D.
K&L Gates LLP
Partner

Douglas Williams
Centanni Park
Founder & Chief Technology Officer

Margarita R. Ochoa-Maya
MD, CDE
Amgen
Senior Medical Director, Rare Disease Unit (TEPEZZA)

David Walton
MBA
T1D Exchange
CEO
Advisory Team

Nestoras Mathioudakis
MD, MHS
Adult endocrinologist at Johns Hopkins Medicine and Associate Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland

Viral Shah
MD
Adult endocrinologist at Indiana University Health and Professor of Medicine in the Division of Endocrinology and Metabolism at Indiana University School of Medicine in Indianapolis, Indiana

Jennifer Sherr
MD, PhD
Pediatric endocrinologist at Yale Medicine and Professor of Pediatrics in the Division of Endocrinology at Yale School of Medicine in New Haven, Connecticut

Jenice Wong
MD, PhD
Pediatric endocrinologist at UCSF Benioff Children’s Hospital and Professor of Pediatrics in the Division of Endocrinology at the University of California, San Francisco
Quality Improvement, Real World Evidence, & Research

Ori Odugbesan, MD, PhD
Associate Director, Health Equity and Quality Improvement

























